XTAI
1304
Market cap447mUSD
Jul 09, Last price
13.40TWD
1D
-2.90%
1Q
-15.99%
Jan 2017
-12.02%
Name
USI Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
USI Corporation operates as a globally active enterprise involved in the creation, production, and sale of a diverse spectrum of chemical and plastic items across continents including Asia, North America, Europe, Africa, and Oceania. Its core business centers on manufacturing various polyethylene types, such as low-density, high-density, and linear low-density resins, as well as ethylene vinyl acetate. The company's comprehensive product lineup extends to vinyl chloride monomer, PVC powder, plastic pellets, polystyrene, and acrylonitrile-butadiene-styrene (ABS) copolymer resins. Additionally, USI produces specialized materials like glass wool products and manganese-zinc soft ferrite powder and cores. Its offerings also encompass a variety of finished plastic goods, including tubes, stretch films, embossed films, industrial multi-layer wraps, plastic cloths, skins, and powders, alongside consumer products such as vest bags, garbage bags, and diapers. Beyond manufacturing, USI provides a range of services, including business management consulting, warehousing for petrochemical raw materials, and commission agency. The company also engages in extensive import and export trade, the distribution of chemical raw materials, the manufacturing of reinforced plastic products, and the wholesale of electronic materials. These products are marketed under established brand names such as EVATHENE, PAXOTHENE, UNITHENE, LINATHENE, and ViviOn. Originally incorporated in 1965 as USI Far East Corporation, USI Corporation's headquarters are located in Kaohsiung, Taiwan.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||